Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Price was the key driver for the period
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.
Subscribe To Our Newsletter & Stay Updated